These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 3266603

  • 21. Sensitivity to antimalarial drugs by Plasmodium falciparum in Goundry, Oubritenga province, Burkina Faso.
    Del Nero L, Lamizana L, Pietra V, Nebié I.
    Parassitologia; 1994 Dec; 36(3):287-93. PubMed ID: 7637999
    [Abstract] [Full Text] [Related]

  • 22. Determination of pyrimethamine in human plasma after administration of fansidar of fansidar-mefloquine by means of high-performance liquid chromatography with fluorescence detection.
    Timm U, Weidekamm E.
    J Chromatogr; 1982 Jun 11; 230(1):107-14. PubMed ID: 6980889
    [Abstract] [Full Text] [Related]

  • 23. Multi-drug resistant malaria in Sri Lanka.
    Gunasekera DP, Perera DP.
    Ceylon Med J; 1996 Dec 11; 41(4):170-1. PubMed ID: 9141768
    [No Abstract] [Full Text] [Related]

  • 24. High prevalence and fixation of Plasmodium vivax dhfr/dhps mutations related to sulfadoxine/pyrimethamine resistance in French Guiana.
    Barnadas C, Musset L, Legrand E, Tichit M, Briolant S, Fusai T, Rogier C, Bouchier C, Picot S, Ménard D.
    Am J Trop Med Hyg; 2009 Jul 11; 81(1):19-22. PubMed ID: 19556560
    [Abstract] [Full Text] [Related]

  • 25. Molecular surveillance of drug-resistance associated mutations of Plasmodium falciparum in south-west Tanzania.
    Schönfeld M, Barreto Miranda I, Schunk M, Maduhu I, Maboko L, Hoelscher M, Berens-Riha N, Kitua A, Löscher T.
    Malar J; 2007 Jan 15; 6():2. PubMed ID: 17224049
    [Abstract] [Full Text] [Related]

  • 26. Assessment of the response in vivo and in vitro of Plasmodium falciparum to sulphadoxine-pyrimethamine in the malarious areas of Iran.
    Edrissian GH, Afshar A, Sayedzadeh A, Mohsseni G, Satvat MT.
    J Trop Med Hyg; 1993 Aug 15; 96(4):237-40. PubMed ID: 8345544
    [Abstract] [Full Text] [Related]

  • 27. Single dose curative and prophylactic efficacy of antimalarial drugs against multi-resistant Plasmodium yoelii nigeriensis.
    Shukla B, Dutta GP.
    J Commun Dis; 1988 Sep 15; 20(3):175-84. PubMed ID: 3256563
    [No Abstract] [Full Text] [Related]

  • 28. Selection of antifolate-resistant Plasmodium falciparum by sulfadoxine-pyrimethamine treatment and infectivity to Anopheles mosquitoes.
    Méndez F, Herrera S, Murrain B, Gutiérrez A, Moreno LA, Manzano M, Muñoz A, Plowe CV.
    Am J Trop Med Hyg; 2007 Sep 15; 77(3):438-43. PubMed ID: 17827356
    [Abstract] [Full Text] [Related]

  • 29. Increased gametocytemia after treatment: an early parasitological indicator of emerging sulfadoxine-pyrimethamine resistance in falciparum malaria.
    Barnes KI, Little F, Mabuza A, Mngomezulu N, Govere J, Durrheim D, Roper C, Watkins B, White NJ.
    J Infect Dis; 2008 Jun 01; 197(11):1605-13. PubMed ID: 18471066
    [Abstract] [Full Text] [Related]

  • 30. Development of resistance by Plasmodium falciparum to sulfadoxine/pyrimethamine in Amhara Region, Northwestern Ethiopia.
    Kassa M, Sileshi M, Mohammed H, Taye G, Asfaw M.
    Ethiop Med J; 2005 Jul 01; 43(3):181-7. PubMed ID: 16370550
    [Abstract] [Full Text] [Related]

  • 31. Chemosuppressive field trials in Thailand. IV. The suppression of Plasmodium falciparum and Plasmodium vivax parasitemias by mefloquine (WR 142,490, A 4-quinolinemethanol).
    Pearlman EJ, Doberstyn EB, Sudsok S, Thiemanun W, Kennedy RS, Canfield CJ.
    Am J Trop Med Hyg; 1980 Nov 01; 29(6):1131-7. PubMed ID: 7004214
    [Abstract] [Full Text] [Related]

  • 32. [Mechanisms and dynamics of drug resistance in Plasmodium falciparum].
    Le Bras J.
    Bull Soc Pathol Exot; 1999 Nov 01; 92(4):236-41. PubMed ID: 10572658
    [Abstract] [Full Text] [Related]

  • 33. Molecular markers of in vivo Plasmodium vivax resistance to amodiaquine plus sulfadoxine-pyrimethamine: mutations in pvdhfr and pvmdr1.
    Marfurt J, de Monbrison F, Brega S, Barbollat L, Müller I, Sie A, Goroti M, Reeder JC, Beck HP, Picot S, Genton B.
    J Infect Dis; 2008 Aug 01; 198(3):409-17. PubMed ID: 18582193
    [Abstract] [Full Text] [Related]

  • 34. In vitro mefloquine resistance of Plasmodium falciparum isolated from the Burmese border region of Thailand.
    Childs GE, Pang L, Wimonwattrawatee T, Pooyindee N, Nanakorn A, Limchitee S, Webster HK.
    Southeast Asian J Trop Med Public Health; 1987 Dec 01; 18(4):438-43. PubMed ID: 3329409
    [Abstract] [Full Text] [Related]

  • 35. Prediction of Plasmodium falciparum resistance to sulfadoxine/pyrimethamine in vivo by mutations in the dihydrofolate reductase and dihydropteroate synthetase genes: a comparative study between sites of differing endemicity.
    Alifrangis M, Enosse S, Khalil IF, Tarimo DS, Lemnge MM, Thompson R, Bygbjerg IC, Rønn AM.
    Am J Trop Med Hyg; 2003 Dec 01; 69(6):601-6. PubMed ID: 14740875
    [Abstract] [Full Text] [Related]

  • 36. Plasmodium yoelii nigeriensis (MDR)-efficacy of oral pyronaridine against multidrug-resistant malaria in Swiss mice.
    Tripathi R, Umesh A, Mishra M, Puri SK, Dutta GP.
    Exp Parasitol; 2000 Mar 01; 94(3):190-3. PubMed ID: 10831384
    [Abstract] [Full Text] [Related]

  • 37. A molecular epidemiologic study of point mutations for pyrimethamine-sulfadoxine resistance of Plasmodium falciparum isolates from Lao PDR.
    Toma H, Imada Y, Vannachone B, Miyagi M, Kobayashi J, Uechi G, Pethuvang R, Manivong K, Phompida S, Sato Y.
    Southeast Asian J Trop Med Public Health; 2005 May 01; 36(3):602-4. PubMed ID: 16124424
    [Abstract] [Full Text] [Related]

  • 38. Mefloquine and sulfadoxine/pyrimethamine resistant Plasmodium falciparum.
    Arnold K.
    Lancet; 1986 Jan 18; 1(8473):154. PubMed ID: 2867368
    [No Abstract] [Full Text] [Related]

  • 39. Antimalarial efficacy of arteether against multiple drug resistant strain of Plasmodium yoelii nigeriensis.
    Dutta GP, Bajpai R, Vishwakarma RA.
    Pharmacol Res; 1989 Jan 18; 21(4):415-9. PubMed ID: 2771860
    [Abstract] [Full Text] [Related]

  • 40. Docetaxel (Taxotere): effectiveness against Plasmodium falciparum in vitro and Plasmodium yoelii nigeriensis in vivo.
    Seitz HM, Gottwald F, Proft J, Wingen F, Maier W.
    Tokai J Exp Clin Med; 1998 Dec 18; 23(6):427-30. PubMed ID: 10622642
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.